Astellas, Poseida Therapeutics Ink Allogeneic Cell Therapy Agreement
Xyphos Biosciences, Inc., a wholly owned subsidiary of Astellas Pharma, and Poseida Therapeutics, Inc, a clinical-stage biopharmaceutical company, have inked a research collaboration and license agreement that entails the development of novel …